A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions
Long-term Documentation of the Utilization of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions (LAPIS-Pso)
1 other identifier
observational
391
1 country
96
Brief Summary
The objective of this NIS is the collection of data on the utilization of Apremilast under routine conditions in Germany. Patients' quality-of-life and treatment satisfaction on treatment with Apremilast in daily practice will be documented. Moreover, physician's and patient's assessments of the effectiveness and safety of Apremilast will be recorded. FPI was 3rd August 2015, LPO was 14th of June 2018. A total of 391 patients have been enrolled.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2015
Typical duration for all trials
96 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2015
CompletedStudy Start
First participant enrolled
August 3, 2015
CompletedFirst Posted
Study publicly available on registry
December 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2018
CompletedFebruary 8, 2022
February 1, 2022
1.8 years
July 29, 2015
February 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in the Dermatology Life Quality Index (DLQI) ≤ 5 or improvement in DLQI by ≥ 5 points at Visit 2 from baseline
DLQI is a simple, compact, and practical questionnaire for use in a dermatology clinical setting to assess limitations related to the impact of skin disease. The instrument contains ten items dealing with the participant's skin. With the exception of Item Number 7, the participant responds on a four-point scale, ranging from "Very Much" (score 3) to "Not at All" or "Not relevant" (score 0). Item Number 7 is a multi-part item, the first part of which ascertains whether the participant's skin prevented them from working or studying (Yes or No, scores 3 or 0 respectively), and if "No," then the participant is asked how much of a problem the skin has been at work or study over the past week, with response alternatives being "A lot," "A little," or "Not at all" (scores 2, 1, or 0 respectively). The DLQI total score is derived by summing all item scores, which has a possible range of 0 to 30, with 30 corresponding to the worst quality of life, and 0 corresponding to the best.
Approximately 4 months
Secondary Outcomes (16)
Change from Baseline in the Dermatology Life Quality Index (DLQI) ≤ 5 or improvement in DLQI by ≥ 5 points at all other visits from baseline.
Up to approximately 52 weeks
Change in the Physician Global Assessment (PGA) Score
Up to approximately 52 weeks
Percent Change in Percent of Affected Body Surface Area (BSA)
Up to approximately 52 weeks
Percent Change in the Psoriasis Area Severity Index (PASI) Score
Up to approximately 52 weeks
Change in the Patient's Global Assessment (PaGA)
Up to approximately 52 weeks
- +11 more secondary outcomes
Study Arms (2)
Patients with ≤ 1 conventional, systemic pre-treatment
After failure (inadequate response/intolerance) to or contraindication for ≤ 1 conventional, systemic pre-treatment
Patients with > 1 conventional, systemic pre-treatment
After failure (inadequate response/intolerance) to or contraindication for \> 1 conventional, systemic pre-treatment
Eligibility Criteria
A total of 500 patients with moderate to severe plaque psoriasis are planned to be enrolled in this NIS. In- and exclusion criteria are derived from the Summary of product characteristics (SmPC) of Apremilast.
You may qualify if:
- The decision for a therapy with Apremilast was made before enrolment and independent of this study.
- Patient ≥ 18 years of age
- Diagnosis of moderate to severe plaque psoriasis
- Inadequate response or intolerance to a previous systemic treatment, or contraindication for systemic therapies.
- Written informed consent by the patient for data recording, statistical analysis, filing and forwarding of the data
You may not qualify if:
- Pregnancy
- Hypersensitivity to apremilast or any of the excipients of the film-coated tablet
- Other criteria according to the Summary of product characteristics (SmPC).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amgenlead
Study Sites (96)
Gertraud Krähn-Senftleben
Blaubeuren Abbey, Baden-Wurttemberg, 89143, Germany
Ralf-Uwe Peter
Blaustein, Baden-Wurttemberg, 89134, Germany
Regina Renner
Esslingen am Neckar, Baden-Wurttemberg, 73728, Germany
Universitätsklinikum Heidelberg - Hautklinik
Heidelberg, Baden-Wurttemberg, 69120, Germany
Ina Reitenbach-Blindt
Karlsruhe, Baden-Wurttemberg, 76133, Germany
Kaiserstraße 231-233
Karlsruhe, Baden-Wurttemberg, 76133, Germany
Naomi Gerhardus
Karlsruhe, Baden-Wurttemberg, 76133, Germany
Johannes Glutsch
Karlsruhe, Baden-Wurttemberg, 76149, Germany
Beate Schwarz
Langenau, Baden-Wurttemberg, 89129, Germany
Astrid Schmieder
Mannheim, Baden-Wurttemberg, 68167, Germany
Katharina Wroblewska
Spaichingen, Baden-Wurttemberg, 78549, Germany
Michael Sticherling
Erlangen, Bavaria, 91054, Germany
Hjalmar Kurzen
Freising, Bavaria, 85354, Germany
Claus Jung
Germering, Bavaria, 82110, Germany
Clarissa Allmacher
Hersbruck, Bavaria, 91217, Germany
Ildiko Sugar-Bunk
Krumbach, Bavaria, 86381, Germany
Sabine Anders
München, Bavaria, 80639, Germany
Hortensia Pfannenstiel
München, Bavaria, 80802, Germany
Technische Universität München - Kilian Eyerich
München, Bavaria, 80802, Germany
Universitätsklinikum Regensburg
Regensburg, Bavaria, 93053, Germany
Andreas Eggert
Würzburg, Bavaria, 97070, Germany
Lars Freitag
Falkensee, Brandenburg, 14612, Germany
Förster-Funke-Allee 104
Kleinmachnow, Brandenburg, 14532, Germany
Silke Thies
Schwedt, Brandenburg, 16303, Germany
Christoph Hartl
Eltville, Hesse, 65343, Germany
Universitätsklinikum Frankfurt, Klinik für Dermatologie, Venerologie und Allergologie
Frankfurt am Main, Hesse, 60590, Germany
Pia Freyschmidt-Paul
Schwalmstadt, Hesse, 34613, Germany
Jutta Ramaker-Brunke
Braunschweig, Lower Saxony, 38114, Germany
Andreas Kleinheinz
Buxtehude, Lower Saxony, 21614, Germany
Marco Averbeck
Cloppenburg, Lower Saxony, 49661, Germany
Florian Schenck
Hanover, Lower Saxony, 30159, Germany
Ulrike Stein
Hanover, Lower Saxony, 30167, Germany
Holger Petering
Hildesheim, Lower Saxony, 31134, Germany
Silke Reinecke
Holzminden, Lower Saxony, 37603, Germany
Reinhard Knöll
Lüneburg, Lower Saxony, 21335, Germany
Christian Kock
Vechta, Lower Saxony, 49377, Germany
Gesundheitszentrum Winsen
Winsen, Lower Saxony, 21423, Germany
Andreas Timmel
Bergen auf Rügen, Mecklenburg-Vorpommern, 18528, Germany
Raimund Paech
Neubrandenburg, Mecklenburg-Vorpommern, 17034, Germany
Theaterplatz 9
Aachen, North Rhine-Westphalia, 52062, Germany
Isaak Effendy
Bielefeld, North Rhine-Westphalia, 33647, Germany
Volker Riesopp
Duisburg, North Rhine-Westphalia, 47249, Germany
Bernhard Korge
Düren, North Rhine-Westphalia, 52349, Germany
Herderstr.71 b
Düsseldorf, North Rhine-Westphalia, 40237, Germany
Dechant-Deckers-Straße 5-7
Eschweiler, North Rhine-Westphalia, 52249, Germany
Universitätsklinikum Essen
Essen, North Rhine-Westphalia, 45147, Germany
Christina Huerkamp
Euskirchen, North Rhine-Westphalia, 53879, Germany
Sebastian Rotterdam
Gelsenkirchen-Feldmark, North Rhine-Westphalia, 45883, Germany
Jörg Brinkmann
Gladbeck, North Rhine-Westphalia, 45964, Germany
Hautartzpraxis
Kleve, North Rhine-Westphalia, 47533, Germany
Rudolf Stadler
Minden, North Rhine-Westphalia, 32429, Germany
Rolf Ostendorf
Mönchengladbach, North Rhine-Westphalia, 41061, Germany
Athanasios Tsianakas
Münster, North Rhine-Westphalia, 48149, Germany
Stefanie Montag
Rheinbach, North Rhine-Westphalia, 53359, Germany
Hautarztpraxis, Steinfeldstr. 5
Stolberg, North Rhine-Westphalia, 52222, Germany
Oliver Mainusch
Velbert, North Rhine-Westphalia, 42551, Germany
Kurt-Kräcker-Str. 47
Wesel, North Rhine-Westphalia, 46485, Germany
Magnus Bell
Andernach, Rhineland-Palatinate, 56626, Germany
Ulrich Blaese
Bendorf, Rhineland-Palatinate, 56170, Germany
Schloss Straße 17
Koblenz, Rhineland-Palatinate, 56068, Germany
Petra Staubach-Renz
Mainz, Rhineland-Palatinate, 55131, Germany
Dirk Maaßen
Maxdorf, Rhineland-Palatinate, 67133, Germany
Marktstr. 20
Neuwied, Rhineland-Palatinate, 56564, Germany
Praxis für Haut- und Geschlechtskrankheiten - Allergologie - Am Johannisborn
Prüm, Rhineland-Palatinate, 54595, Germany
Ralph von Kiedrowski
Selters, Rhineland-Palatinate, 56242, Germany
Mohammad Asefi
Simmern, Rhineland-Palatinate, 55469, Germany
Karolin Schneider
Chemnitz, Saxony, 09116, Germany
Beatrice Gerlach
Dresden, Saxony, 01097, Germany
Liane John
Dresden, Saxony, 01159, Germany
Mary-Krebs-Straße 1
Dresden, Saxony, 01219, Germany
Stefan Beissert
Dresden, Saxony, 01307, Germany
Bernhard-Göring-Str. 162
Leipzig, Saxony, 04277, Germany
Riebeckstraße 65
Leipzig, Saxony, 04317, Germany
Schweizergartenstr. 2a
Wurzen, Saxony, 04808, Germany
Puschkinstr. 110
Eilenburg, Saxony-Anhalt, 04838, Germany
Franckestr. 1
Magdeburg, Saxony-Anhalt, 39104, Germany
Jens Ulrich
Quedlinburg, Saxony-Anhalt, 06484, Germany
Gabriela Fiedler
Weißenfels, Saxony-Anhalt, 06667, Germany
Harald Brüning
Kiel, Schleswig-Holstein, 24148, Germany
Universitätsklinikum Schleswig-Holstein
Lübeck, Schleswig-Holstein, 23562, Germany
Christian Meewes
Neumünster, Schleswig-Holstein, 24534, Germany
Jens Thieme
Artern, Thuringia, 06556, Germany
Mario Pawlak
Heilbad Heiligenstadt, Thuringia, 37308, Germany
Raoul Hasert
Berlin, 10117, Germany
Klaus Spickermann
Berlin, 10247, Germany
Jens Olaf Mielcke
Berlin, 10777, Germany
Albert-Einstein-Str. 2
Berlin, 12489, Germany
Hautarztpraxis Zahn
Berlin, 13187, Germany
Maria Manasterski
Berlin, 13507, Germany
Martin Miehe
Berlin, 13507, Germany
Uwe Schwichtenberg
Bremen, 28779, Germany
Matthias Augustin
Hamburg, 20246, Germany
Kristian Reich
Hamburg, 20354, Germany
Christian Mensing
Hamburg, 22391, Germany
Johannes-R.-Becher-Straße 24
Königs Wusterhausen, 15711, Germany
Florian Kreuziger
Vilshofen, 94474, Germany
Related Publications (1)
Reich K, Korge B, Magnolo N, Manasterski M, Schwichtenberg U, Staubach-Renz P, Kaiser S, Roemmler-Zehrer J, Gomez NN, Lorenz-Baath K. Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO. Dermatol Ther (Heidelb). 2022 Jan;12(1):203-221. doi: 10.1007/s13555-021-00658-x. Epub 2021 Dec 15.
PMID: 34913153DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
MD
Amgen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2015
First Posted
December 10, 2015
Study Start
August 3, 2015
Primary Completion
June 8, 2017
Study Completion
June 14, 2018
Last Updated
February 8, 2022
Record last verified: 2022-02